Does NAD+ Work for Women’s Energy and Aging?

What is NAD+ and does it work for energy and aging?

Quick answer

Oral NR and NMN reliably raise NAD-related blood markers, but human studies have not shown a dependable improvement in women’s energy, libido, hormones, exercise capacity, or longevity. If you are considering NAD+, start with a specific goal and review the option with a clinician.

Reviewed by Taylor Anderson, RN · Aesthetic Registered Nurse · Updated September 4, 2026

Key takeaways

Oral NR and NMN consistently raise NAD-related markers in human studies.
A 2021 study in prediabetic women found 250 mg of NMN raised NAD in blood immune cells, but not in muscle.
Human results for energy, metabolism, vascular health, exercise, and healthy aging are mixed or limited to individual endpoints.
A 2025 randomized study found that 1 g of NR and 1 g of NMN roughly doubled whole-blood NAD+ after 14 days, while 0.5 g of NAM did not.
Short studies generally found NR and NMN well tolerated, but long-term and higher-dose safety remains uncertain.
Get Hot or Die currently prescribes and dispenses medication, with suitability assessed through its personalized quiz.

Quick answer: Oral NR and NMN reliably raise NAD-related blood markers, but human studies have not shown a dependable improvement in women’s energy, libido, hormones, exercise capacity, or longevity. If you are considering NAD+, start with a specific goal and review the option with a clinician.

You want energy that lasts through the day and aging that still feels vital rather than draining. Can raising NAD+ help women feel or function better, or does the evidence stop at a lab result?

The clearest answer is biochemical. Oral nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) raise NAD-related measures in human blood or cells. Benefits beyond that, including better daily energy, libido, hormone balance, exercise capacity, or longer healthspan, remain inconsistent.

NAD+ is a coenzyme that cells use in metabolism and energy-related reactions. It also participates in cellular stress-response pathways. NAD+ metabolism connects to aging biology, but consistent age-related declines have appeared in only a limited number of human studies. The positive longevity findings are much stronger in rodents than in people.

What NAD+ does in the body

NAD+ helps cells turn fuel into usable energy and supports processes linked to mitochondrial function, DNA repair, and cellular stress responses. That biology makes NAD+ interesting for women dealing with fatigue, changing metabolic health, or the physical shifts of midlife.

It does not make every claim about NAD+ true. Raising a precursor-related blood marker does not automatically mean that you will have more energy, higher desire, better hormones, or slower aging.

Term	Plain-English meaning
NAD+	A coenzyme involved in cellular metabolism, energy-related reactions, and stress-response pathways.
NR	Nicotinamide riboside, a precursor the body can use to make NAD+.
NMN	Nicotinamide mononucleotide, another NAD+ precursor.
NAM	Nicotinamide, a vitamin B3-related compound that does not behave exactly like NR or NMN in every study.

A 2021 trial in prediabetic women with obesity found that 250 mg of NMN per day raised NAD in blood immune cells but not in muscle. The study did not show clear downstream improvements in insulin sensitivity or body composition that would translate into the energy or libido many women want. The finding appears in a review of human cardiometabolic research published in PMC.

If fatigue or low desire is part of a broader perimenopause picture, the hormones hub may give you more useful context than treating a single lab marker as the whole answer.

What human studies show about energy and aging

Human studies consistently show target engagement, meaning NR and NMN change NAD-related measures. They do not consistently show that women feel more energetic or age more slowly.

A 2026 systematic review examined 33 human intervention studies. It found consistent biochemical changes with oral NR and NMN, while metabolic, vascular, performance, and other healthspan-related outcomes were mixed, often null, or limited to one endpoint. The review included 80 rodent studies, where NAD+ augmentation produced more frequent improvements than it did in human trials.

Outcome	What the human evidence shows	What not to assume
NAD-related biomarkers	Oral NR and NMN consistently raise circulating or cellular NAD-related metabolites.	A higher marker is not the same as a felt energy benefit.
Energy and performance	Results vary by study and endpoint, with many null findings.	NAD+ is not a proven universal treatment for fatigue or exercise performance.
Women-specific evidence	NMN increased NAD in blood immune cells in one study of prediabetic women with obesity, but not in muscle.	That result does not establish a libido, hormone, energy, or aging benefit.
Exercise outcomes	A registered trial is testing exercise tolerance, VO₂peak, lactate threshold, and NAD-related metabolites in healthy older adults.	Planned outcomes are not reported results.
Healthy aging	Human healthspan and longevity results remain limited and mixed.	Positive rodent findings are not human proof.

The registered study NCT07144527 compares a twice-daily 1,000 mg NMN formulation with conventional NMN in healthy older adults. It measures exercise tolerance and metabolic markers. As of September 4, 2026, the trial record does not provide results.

Perimenopause can bring fatigue and lower desire through several overlapping factors, including sleep disruption, changing estrogen levels, thyroid problems, and iron deficiency. Published NAD+ trials have not established a consistent fix for those causes. Practitioner reports of feeling more energetic remain anecdotal rather than proof of a reliable treatment effect.

NR, NMN, NAM, and IV NAD+ compared

The human data currently favor oral precursors for changing NAD-related markers. IV and intramuscular NAD+ do not have comparable published outcomes trials for anti-aging or wellness.

Option	Human evidence	Practical conclusion
Oral NR	In a 14-day randomized study, 1 g per day increased whole-blood NAD+ by roughly twofold compared with placebo.	Supported for a biomarker change, not proven superior for energy or aging.
Oral NMN	In the same study, 1 g per day also increased whole-blood NAD+ by roughly twofold.	Similar target engagement to NR in that study, without proof of broader clinical superiority.
NAM	A 0.5 g-per-day dose did not produce the same chronic whole-blood NAD+ increase over 14 days.	Vitamin B3-related compounds should not be treated as interchangeable.
IV or IM NAD+	A 2026 systematic review found no eligible human outcomes trials evaluating parenteral NAD+ for anti-aging or wellness.	Ask which human outcome the treatment is expected to improve and what data support that expectation.

The 2025 Nature Metabolism study randomized 67 healthy adults to NR 1 g, NMN 1 g, NAM 0.5 g, or placebo for 14 days. After 14 days, NR and NMN increased whole-blood NAD+ by about twofold compared with placebo. NAM did not produce the same chronic increase.

The study recorded one probable NR-related hypotension event and one probable NMN-related headache. It was short, and it was not designed to prove a lasting energy or aging benefit.

For care, Get Hot or Die is a current option that prescribes and dispenses medication when the personalized quiz identifies a suitable service. Specific prescribed medications, prices, and fulfillment details are not available in the information checked for this comparison. IV NAD+ remains a separate treatment format with weaker published outcome evidence, regardless of the size of a measured plasma peak.

Safety and study doses

Short studies generally found NR and NMN well tolerated. Those studies involved healthy adults over weeks or a few months, so they do not establish how a particular woman will respond over years or with a complex medication list.

Study context	Finding	Limit
NMN at 250 mg per day for 12 weeks	Whole-blood NAD+ increased, with no obvious adverse effects or clinical laboratory abnormalities in healthy subjects.	The participants were healthy and the study was relatively short.
NMN at 1,250 mg per day for up to four weeks	In 31 healthy adults aged 20 to 65, no severe adverse events were observed and measured clinical changes stayed within physiological variation.	This does not establish long-term safety.
NR or NMN at 1 g per day for 14 days	Both raised NAD+ substantially and were generally well tolerated. One probable NR-related hypotension event and one probable NMN-related headache occurred.	Small, short studies cannot predict every individual response.

The 2022 NMN safety study followed 31 healthy adults who took 1,250 mg daily for up to four weeks. Researchers found no severe adverse events or clinical changes beyond physiological variation. A broader review of NMN and NR research also notes that high-dose and long-term safety still needs more study.

Published study doses describe research conditions, not a universal plan for women. A clinician reviewing your health history, medications, symptoms, and reason for fatigue can help decide whether an NAD+ precursor belongs in the conversation. If low energy or desire could reflect low iron, sleep apnea, thyroid disease, or perimenopause, identifying that cause may be more useful than adding a precursor.

How to decide whether NAD+ fits your goal

Start with the outcome you want to change. A biomarker rise will not feel like a win if your real goal is getting through the afternoon without crashing or feeling more interested in sex.

Your goal	How to think about the evidence	Sensible question to ask
A measurable NAD-related change	Oral NR and NMN have the clearest and most repeatable human biomarker signal.	What marker will be measured, and why does it matter for my goal?
More daily energy, libido, or hormone support	Current human evidence does not establish a reliable benefit for these outcomes.	What other causes of fatigue or low desire should be checked first?
Healthy-aging support	Human results are mixed, and a higher NAD+ marker is not proof of longer life.	What human functional outcome would show that it is helping?
IV or IM treatment	No eligible human anti-aging or wellness outcomes trials were identified in the 2026 review.	What outcome, duration, and safety data support this format?
Personalized care	Get Hot or Die currently prescribes and dispenses medication when its quiz identifies a suitable option.	What service and medication details apply to me?

The most defensible choice is goal-first. Oral NR or NMN can change NAD-related biomarkers, but a claim about symptoms or aging needs stronger human outcome evidence. If low desire is your main concern, compare that question with options discussed in PT-141 for women rather than assuming NAD+ is the answer.

If you want help sorting your symptoms, goals, and budget into a realistic care option, take the Get Hot or Die personalized quiz.

Sources and study notes

NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence, published April 1, 2026. This review included 33 human intervention studies and found consistent biomarker changes but mixed functional and healthspan outcomes.
NAD+ precursor supplementation in human ageing: clinical evidence and challenges, Nature Metabolism, published October 13, 2025. It notes that consistent age-related NAD+ decline has appeared in only a limited number of human studies and that human clinical benefits remain limited.
The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans, Nature Metabolism, 2025. This was the randomized 14-day study of NR, NMN, NAM, and placebo.
NAD+ precursors NMN and NR: Potential dietary contribution to health, a review of human safety and metabolism findings.
NAD+ metabolism and cardiometabolic health: the human evidence, including the trial in prediabetic women with obesity.
Safety evaluation of beta-nicotinamide mononucleotide oral administration in healthy adult men and women, published August 24, 2022.
The efficacy and safety of beta-nicotinamide mononucleotide supplementation in healthy middle-aged adults, a randomized, multicenter NMN trial.
NCT07144527, a registered exercise-tolerance study in healthy older adults. Results were not available on September 4, 2026.
NAD+ injections vs IV vs oral, PeakedLabs, checked August 2026. This source discusses route differences but does not replace peer-reviewed outcomes research.

Frequently asked questions

What is NAD+?

NAD+ is a coenzyme involved in cellular metabolism, energy-related reactions, and cellular stress-response pathways.

Does NAD+ increase energy for women?

NR and NMN can raise NAD-related markers, but current human evidence does not show a dependable improvement in daily energy.

Is NMN better than NR?

One randomized study found that 1 g of NMN and 1 g of NR produced similar whole-blood NAD+ increases. Neither has been proven better for energy or aging.

Can NAD+ slow aging?

Animal findings are encouraging, but human healthspan and longevity benefits remain unproven.

Is IV NAD+ more effective than oral NR or NMN?

Current reviews do not establish superior anti-aging or wellness outcomes for IV or intramuscular NAD+.

Are NAD+ supplements safe?

Short studies were generally well tolerated, but they cannot establish the long-term or higher-dose safety of NR or NMN.

Ready to make a move?

Answer three questions to see the options, prices, and providers that fit your goals.

See My Plan

Questions women actually ask